Hydrodynamic Tail Vein Injection as a Simple Tool for Yielding Extended Transgene Expression in Solid Tumors

Area of Science:

• * Molecular Biology
• * Gene Therapy
• * Oncology

Background:

• * Hydrodynamic tail vein injection is a recognized in vivo transfection method for high gene expression, primarily in the liver.
• * Its application in cancer gene therapy for hepatic and non-hepatic cancers is established, but intratumor transgene expression in non-hepatic tumors remains understudied.
• * Understanding transgene expression in non-hepatic tumors is crucial for advancing gene therapy strategies.

Purpose of the Study:

• * To investigate the efficacy of hydrodynamic injection for achieving extended transgene expression in non-hepatic solid tumors.
• * To evaluate the potential of this method for cancer gene therapy targeting tumors outside the liver.
• * To determine if hydrodynamic injection can be a viable tool for intratumor gene delivery in solid tumors.

Main Methods:

• * Hydrodynamic injection of plasmid DNA encoding beta-galactosidase (LacZ) was performed.
• * The plasmid DNA used was LacZ pDNA.
• * Transgene expression was assessed in subcutaneously implanted murine solid tumors.

Main Results:

• * Extended transgene expression of beta-galactosidase (LacZ) was observed in subcutaneously implanted murine solid tumors.
• * The nonsecretory protein LacZ demonstrated expression within the tumor.
• * This indicates successful gene delivery and expression in a non-hepatic tumor model.

Conclusions:

• * Hydrodynamic injection can achieve significant transgene expression in solid tumors, not just the liver.
• * This method presents a powerful tool for gene delivery to non-hepatic tumors.
• * The findings support the potential of hydrodynamic injection for broader applications in cancer gene therapy.